Top news of the week: 14.11.2022.
Antibody
Immunity
T helper cell
Blood
Thymus
Adaptive immune system
invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022
https://t.co/aVgHLgDFYE
OpenPress release: invIOs presents positive patient data from ongoing Phase 1b trial of APN401 cell therapy in advanced solid tumors at SITC 2022
Poster presentation shows treatment with APN401, an autologous cell therapy product targeting the master immune checkpoint Cbl-b, resulted in stabilization of disease for more …